14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CTRE vs NHI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over National Health Investors (NHI) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CTRE carries a Unified Composite Score of 46.6/100 (HOLD) at $37.53 (22.3x Forward P/E, 66.2% operating margin), whereas NHI carries 31.7/100 (SELL) at $61.47 (18.2x Forward P/E, 42.5% operating margin).
Technical & Structure Timing Caution: CTRE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 52.3); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CTRE vs NHI. Trailing 12-month operating profitability (CTRE 66.2% vs NHI 42.5%) and valuation multiples (CTRE 22.3x vs NHI 18.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the REIT - Healthcare Facilities value chain with $9.8B market capitalization and 66.2% operating margin.
OpEx & R&D Reinvestment29.5% of Rev ($182M)
90D Engineering Disclosures0 Published
NHI Moat ProfileHigh-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $3.2B market capitalization and 42.5% operating margin.
OpEx & R&D Reinvestment28.7% of Rev ($132M)
90D Engineering Disclosures0 Published
Investor FAQ CTRE vs NHI Key Questions & Quantitative Answers
As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over National Health Investors (NHI) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CTRE carries a Unified Composite Score of 46.6/100 (HOLD) at $37.53 (22.3x Forward P/E, 66.2% operating margin), whereas NHI carries 31.7/100 (SELL) at $61.47 (18.2x Forward P/E, 42.5% operating margin). Technical & Structure Timing Caution: CTRE trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 52.3); meanwhile NHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CTRE leads the Growth & Scale pillar: CTRE posts +33.2% YoY revenue growth and -0.8% YoY earnings growth on $615M TTM revenue (95.7% gross margin, 66.2% operating margin), compared with NHI at +26.3% YoY revenue growth and N/A YoY earnings growth on $459M TTM revenue (71.2% gross margin, 42.5% operating margin). On trailing 12-month operating scale, CTRE generates $615M in USD-normalized revenue versus $459M for NHI. In operating R&D and SG&A reinvestment, CTRE deploys 29.5% of Rev ($182M) (0 90-day corporate R&D disclosures) versus 28.7% of Rev ($132M) (0 disclosures) for NHI.
NHI screens cheaper on headline valuation multiples. CTRE trades at 22.3x Forward P/E, 24.0x Trailing P/E, 1.26x PEG, and 18.6x EV/Revenue (78.8% FCF margin), whereas NHI trades at 18.2x Forward P/E, 4.6x Trailing P/E, 4.76x PEG, and 6.9x EV/Revenue (63.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CTRE (7.7% ROE) versus NHI (38.6% ROE) capital efficiency.
In options market volatility and institutional positioning, CTRE carries 24.7% implied volatility (10th %ile, Compressed (<25th %ile)), a 6.12x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.15β · 28% Vol realized risk). By comparison, NHI carries 19.1% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.21β · 34% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.